Bryostatin Activates CAR T-Cell Antigen-Non-Specific Killing (CTAK), and CAR-T NK-Like Killing for Pre-B ALL, While Blocking Cytolysis of a Burkitt Lymphoma Cell Line.

MLA

Wang, Lingyan, et al. “Bryostatin Activates CAR T-Cell Antigen-Non-Specific Killing (CTAK), and CAR-T NK-Like Killing for Pre-B ALL, While Blocking Cytolysis of a Burkitt Lymphoma Cell Line.” Frontiers in Immunology, vol. 13, Feb. 2022, p. 825364. EBSCOhost, https://doi.org/10.3389/fimmu.2022.825364.

APA

Wang, L., Zhang, Y., Anderson, E., Lamble, A., & Orentas, R. J. (2022). Bryostatin Activates CAR T-Cell Antigen-Non-Specific Killing (CTAK), and CAR-T NK-Like Killing for Pre-B ALL, While Blocking Cytolysis of a Burkitt Lymphoma Cell Line. Frontiers in Immunology, 13, 825364. https://doi.org/10.3389/fimmu.2022.825364

Chicago

Wang, Lingyan, Yue Zhang, Eden Anderson, Adam Lamble, and Rimas J Orentas. 2022. “Bryostatin Activates CAR T-Cell Antigen-Non-Specific Killing (CTAK), and CAR-T NK-Like Killing for Pre-B ALL, While Blocking Cytolysis of a Burkitt Lymphoma Cell Line.” Frontiers in Immunology 13 (February): 825364. doi:10.3389/fimmu.2022.825364.